N-terminal pro-brain natriuretic peptide and resistance to chronic therapy with 75 mg acetylsalicylic acid assessed by point-of-care test - prospective single center study.

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 5 - Primary care Cardiovascular Disease in Primary Care ESC Premium Access ESC Congress 2019

ESC 365 is supported by

ESC 365 is supported by